Recce Pharmaceuticals
Pharmaceutical company focusing on synthetic anti-infectives.
AI Overview
With $452K in lobbying spend across 15 quarterly filings, Recce Pharmaceuticals is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2023 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2023 | $180K |
| 2024 | $180K |
| 2025 | $92K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Recce Pharmaceuticals disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: MED, Health Issues
Supporting client with policy and advocacy related to synthetic anti-infectives used to address the urgent global health threat posed by superbugs and emerging viral pathogens.
Development of anti-infectives for use responding to military burns.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.